← TANDEM DIABETES CARE INC
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||
| Net Income (Loss) Attributable to Parent | ($83.4m) | ($73.0m) | ($122.6m) | ($24.8m) | ($34.4m) | $15.6m | ($94.6m) | ($222.6m) | ($96.0m) | ($204.7m) | |
| Net Income (Loss) Available to Common Stockholders, Basic | — | — | — | — | — | $15.6m | ($94.6m) | ($222.6m) | — | — | |
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | — | — | ($122.6m) | ($24.8m) | ($34.4m) | $15.6m | ($94.6m) | ($222.6m) | ($96.0m) | ($204.7m) | |
| Depreciation, Depletion and Amortization | $5.5m | $6.9m | $5.8m | $6.1m | $10.5m | $13.8m | $14.3m | $15.7m | $16.6m | $17.7m | |
| Amortization of Debt Issuance Costs | — | — | — | — | — | $1.7m | $1.9m | $2.2m | $2.1m | $1.9m | |
| Amortization of Debt Issuance Costs and Discounts | $274k | $1.9m | $1.7m | $0 | $10.1m | $1.7m | $1.9m | $2.2m | $2.1m | $1.9m | |
| Amortization of Intangible Assets | $300k | $300k | $300k | $300k | $1.2m | $2.2m | $2.0m | $1.9m | $1.9m | $2.5m | |
| Deferred Income Tax Expense (Benefit) | — | — | — | ($25k) | ($2.1m) | $0 | $0 | $0 | $0 | $0 | |
| Share-based Payment Arrangement, Noncash Expense | $11.7m | $12.6m | $23.7m | $58.1m | $58.4m | $60.8m | $84.9m | $88.1m | $101.4m | $92.4m | |
| Share-based Payment Arrangement, Expense | $11.7m | $12.6m | $23.7m | $58.1m | $58.4m | $60.8m | $84.9m | $88.1m | $101.4m | $92.4m | |
| Equity Method Investment, Other than Temporary Impairment | — | — | — | — | — | — | — | — | $2.0m | — | |
| Impairment of Intangible Assets, Finite-lived | — | — | — | — | — | $0 | — | — | — | — | |
| Gain (Loss) on Extinguishment of Debt | — | $0 | ($5.3m) | $0 | $0 | — | $0 | $0 | ($1.3m) | $0 | |
| Income (Loss) from Equity Method Investments | — | — | — | — | — | — | $0 | $0 | ($2.1m) | ($14.2m) | |
| Income Tax Expense (Benefit) | ($15k) | $8k | $51k | $149k | ($1.9m) | $335k | $1.7m | $2.4m | $4.2m | $4.4m | |
| Interest Expense Nonoperating | — | — | — | — | — | — | — | — | $7.4m | $7.9m | |
| Other Nonoperating Income (Expense) | ($5.4m) | ($10.1m) | ($77.9m) | ($7.9m) | ($28.3m) | ($6.8m) | ($4k) | $13.0m | $7.3m | ($13.0m) | |
| Changes in operating assets and liabilities: | |||||||||||
| Additional Financial Items | |||||||||||
| Increase (Decrease) in Accounts Receivable | ($2.3m) | $10.4m | $15.8m | $13.7m | $38.8m | $31.0m | $7.8m | ($4.3m) | $20.8m | $56.8m | |
| Increase (Decrease) in Inventories | $6.9m | $5.9m | ($6.8m) | $31.0m | $15.4m | $5.0m | $42.5m | $46.1m | ($5.8m) | ($24.8m) | |
| Increase (Decrease) in Accounts Payable | $3.2m | ($2.0m) | $1.6m | $8.9m | $1.1m | $10.3m | $24.5m | ($4.9m) | ($2.4m) | $2.2m | |
| Inventory Write-down | $3.3m | $26k | $607k | $2.4m | ($57k) | $467k | — | — | — | — | |
| Operating Expenses | $101.6m | $107.0m | $134.5m | $210.9m | $268.5m | $353.6m | $505.8m | $600.9m | $588.7m | $733.3m | |
| Net Cash Provided by (Used in) Operating Activities | ($61.2m) | ($66.1m) | ($8.3m) | $41.9m | $24.7m | $111.4m | $50.5m | ($31.8m) | $24.2m | ($9.7m) | |
| Cash flows from investing activities: | |||||||||||
| Payments to Acquire Property, Plant, and Equipment | $8.9m | $5.7m | $3.0m | $19.5m | $27.4m | $14.2m | $34.1m | $26.8m | $19.2m | $19.9m | |
| Net Cash Provided by (Used in) Investing Activities | $10.4m | $2.8m | ($90.7m) | ($57.0m) | ($296.1m) | ($186.9m) | $33.2m | ($85.7m) | ($23.5m) | $72.9m | |
| Cash flows from financing activities: | |||||||||||
| Proceeds from Issuance of Common Stock | $2.3m | $570k | $2.4m | $23.9m | $66.9m | $51.3m | $17.5m | $4.2m | ($6.7m) | $2.6m | |
| Payments for Repurchase of Common Stock | — | — | — | — | — | — | $0 | $0 | $30.0m | $0 | |
| Proceeds from (Payments for) Other Financing Activities | — | — | — | — | — | — | ($675k) | ($71k) | $183k | $0 | |
| Net Cash Provided by (Used in) Financing Activities | $52.3m | $32.4m | $117.2m | $24.2m | $314.4m | $51.9m | $16.9m | $4.1m | $8.4m | ($43.4m) | |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | $0 | $0 | $191k | $387k | $153k | $827k | ($212k) | $1.3m | $1.6m | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | — | $0 | $18.1m | $9.3m | $43.4m | ($23.4m) | $101.3m | ($113.6m) | $10.4m | $21.4m | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | — | — | $51.2m | $94.6m | $71.2m | $172.5m | $58.9m | $69.2m | $90.6m | |
| Cash, Cash Equivalents, and Short-term Investments | $53.5m | — | $129.0m | $176.5m | — | — | — | — | — | — | |
| Supplemental disclosure of cash flow information: | |||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating Activities | $4.4m | $7.9m | $10.8m | $0 | $2.7m | $4.3m | $4.3m | $7.6m | $3.1m | $5.0m | |
| Income Taxes Paid, Net | $23k | $22k | $16k | $67k | $177k | $260k | $411k | $1.9m | $3.1m | $5.1m |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.